GB1318169A - Moulded pharmaceutical compositions - Google Patents

Moulded pharmaceutical compositions

Info

Publication number
GB1318169A
GB1318169A GB2075472A GB2075472A GB1318169A GB 1318169 A GB1318169 A GB 1318169A GB 2075472 A GB2075472 A GB 2075472A GB 2075472 A GB2075472 A GB 2075472A GB 1318169 A GB1318169 A GB 1318169A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
moulded
moulding
pharmaceutical
galactomannan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2075472A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of GB1318169A publication Critical patent/GB1318169A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1318169 Pharmaceutical compositions comprising galactomannan MERCK PATENT GmbH 4 May 1972 [19 June 1971] 20754/72 Heading A5B A pharmaceutical moulding, from which there is delayed release of active material, is characterised in that the moulding contains at least 20% by weight of galacto mannan.
GB2075472A 1971-06-19 1972-05-04 Moulded pharmaceutical compositions Expired GB1318169A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712130545 DE2130545A1 (en) 1971-06-19 1971-06-19 Pharmaceutical molded body

Publications (1)

Publication Number Publication Date
GB1318169A true GB1318169A (en) 1973-05-23

Family

ID=5811246

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2075472A Expired GB1318169A (en) 1971-06-19 1972-05-04 Moulded pharmaceutical compositions

Country Status (5)

Country Link
BR (1) BR7203711D0 (en)
DE (1) DE2130545A1 (en)
ES (1) ES403972A1 (en)
FR (1) FR2143059B1 (en)
GB (1) GB1318169A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0234670A2 (en) 1986-01-18 1987-09-02 The Boots Company PLC Sustained-release pharmaceutical formulation containing xanthan gum
AU603098B2 (en) * 1986-03-07 1990-11-08 Eurand International S.P.A. Formulation for preparing sustained released drugs
AT397345B (en) * 1990-04-04 1994-03-25 Chemiefaser Lenzing Ag PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE BASED ON HEMICELLULOSES
US6039980A (en) * 1996-01-29 2000-03-21 Edward Mendell Co., Inc. Sustained release excipient

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0481240B1 (en) * 1990-10-18 1996-12-11 Basf Aktiengesellschaft Galactomannan derivate for the encapsulation or incorporation of drugs
AU709413B2 (en) * 1994-12-01 1999-08-26 Amarin Development Ab Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants
MX9704079A (en) * 1994-12-01 1997-12-31 Cibus Pharmaceutical Inc Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants.
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0234670A2 (en) 1986-01-18 1987-09-02 The Boots Company PLC Sustained-release pharmaceutical formulation containing xanthan gum
US5415871A (en) * 1986-01-18 1995-05-16 The Boots Company Plc Therapeutic agents
AU603098B2 (en) * 1986-03-07 1990-11-08 Eurand International S.P.A. Formulation for preparing sustained released drugs
AT397345B (en) * 1990-04-04 1994-03-25 Chemiefaser Lenzing Ag PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE BASED ON HEMICELLULOSES
US6039980A (en) * 1996-01-29 2000-03-21 Edward Mendell Co., Inc. Sustained release excipient

Also Published As

Publication number Publication date
BR7203711D0 (en) 1973-11-01
ES403972A1 (en) 1975-05-16
FR2143059B1 (en) 1975-06-20
DE2130545A1 (en) 1972-12-21
FR2143059A1 (en) 1973-02-02

Similar Documents

Publication Publication Date Title
GB1261230A (en) Acyl-substituted insulins
GB1318169A (en) Moulded pharmaceutical compositions
CA976186A (en) N, n'-thio-bis-carboxylic acid amides as vulcanization retarders
GB1464200A (en) Pharmaceutical composition
GB1403900A (en) Pharmaceutical composition
CA974256A (en) Production of n,n,n',n'-tetraacetylethylenediamine
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
AU476979B2 (en) 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof
CA1008461A (en) 3,4-dihydroxyphenyl-alamines as active ingredients of antioxidant compositions
CA941375A (en) 1,2,4-oxidiazole salt, a process for the preparation thereof and pharmaceutical composition comprising same
CA945544A (en) 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS
IL37481A0 (en) The preparation of 2,2,4,4-tetrafluoro-1,3-benzodioxans
CA952101A (en) Produits intermediaires utiles pour la preparation de certains 4,9,11-trienes
CA836045A (en) Process for the preparation of cyclododeca-1,5,9-triene
IL36499A0 (en) 1,2,4-oxadiazoline derivatives,their preparation and pharmaceutical compositions containing them
CA855699A (en) Preparation of 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines
CA830515A (en) Preparation of 1-n-butyl-2',6'-pipecoloxylidide
CA835396A (en) Preparation of 3,4-dimethyl-8-nitroquinoline
CA836599A (en) Process for the preparation of 2,3-dihydro-2,2,4-trimethyl-7-benzofuranol
JPS5259650A (en) Preparation of granular composite stabilizer for polyvinyl chloride
AU6366569A (en) Novel products, processes and'compositions
IE34304B1 (en) 1alpha,2alpha;6beta,7beta-dimethylene-steroids
CA728123A (en) 17.alpha.-LOWER ALKYL, LOWER ALKENYL OR LOWER ALKINYL-.DELTA.5-ESTRENE-3,17-DIOL AND ITS ESTERS
AU2662971A (en) Production of 1, 1' peroxydicyclohexylamine
CA850221A (en) Continuous production of high molecular weight nylon 6,6

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee